Instituto Dante Pazzanese de Cardiologia   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: São Paulo Brazil (1954)

Organization Overview

First Clinical Trial
2004
NCT00123916
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Instituto Dante Pazzanese de Cardiologia | Instituto Date Pazzanese de Cardiologia